HBS AG
HCV Test Kit
DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit Real-Time OneStep RT-PCR based assay system for detection of SARS-CoV-2 [Product Approval] U.S FDA EUA, Health Canada IO, CE-IVD marked The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit is a real-time reverse transcriptase (RT)-PCR test intended for the qualitative detection of nucleic acid from SARS-CoV-2 in nasopharyngeal swabs, oropharyngeal (throat) swabs, anterior nasal swabs, mid-turbinate nasal swabs, nasal aspirates, nasal washes, bronchoalveolar lavage (BAL) fluid and sputum from individuals suspected of COVID-19 by their healthcare provider. Results are for the identification of SARS-CoV-2 RNA. The SARS-CoV-2 RNA is generally detectable in respiratory specimens during the acute phase of infection. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. The agent detected may not be the definite cause of disease. Positive results do not rule out bacterial infection or co-infection with other viruses. Negative results do not preclude SARS-CoV-2 infection and should not be used as the sole basis for patient management decisions. Negative results must be combined with clinical observations, patient history, and epidemiological information. The DiaPlexQ Novel Coronavirus (2019-nCoV) Detection Kit is intended for use by qualified clinical laboratory personnel specifically instructed and trained in the techniques of real-time PCR and in vitro diagnostic procedures.
Hygisun rapid test is used for the qualitative detection of COVID19 in posterior oropharyngeal saliva, sputum and stool samples. Home use. Stock in Germany.
We are A3 International, a company located in the 22 @ district of Barcelona and we are dedicated to the import and export of all kinds of products. Currently with the focus of providing material to combat COVID-19. - Saliva and nasopharyngeal antigen test from - Syringes from - FFP2 masks - Isolation and surgical gowns - Protective suits
A pregnancy test can confirm if a woman is pregnant. The test can be carried out at home or in the doctor's office. A pregnancy test is around 99 percent reliable. It works by measuring levels of a hormone called human chorionic gonadotropin (HCG). Categories - OTC - Over The Counter Product
I-can is a test kit, which helps to detect pregnancy. Every woman is excited to know whether she has conceived or not. This I- can kit will help you to confirm pregnancy. I-can detects pregnancy in five minutes. It confirms pregnancy by detecting the presence of human chorionic gonadotropin hormone (pregnancy hormone) in the urine. It gives an accurate estimation of pregnancy. Major benefit of this kit is that it is very simple to use and you do not require any assistance to determine pregnancy by using this kit.
Products - Human Chorionic Gonadotropin (HCG) Test Midstream (Colloidal Gold Immunochromatographic Assay) Product Description - Sensitivity: 25 mIU/ml Accuracy: > 99.5% ISO13485 & CE approved INTENDED USE Easy-Sweet hCG Test Midstream is an in vitro diagnostic (IVD) qualitative test for rapid detection of hCG in urine. This test is designed for self-testing use only. PRINCIPLE Easy-Sweet. hCG Midstream is two-side sandwich immunoassay for the qualitative determination of human chorionic gonadotropin (hCG) in urine. The membrane was precoated with anti alpha hCG capture antibodies on the test band region and goat anti mouse on the control band region. During the test, the urine specimen is allowed to react with anti beta hCG monoclonal antibody-colloid gold conjugate, which was predried on the test Midstream. The mixture then moves forward on the membrane by the capillary action. For a positive specimen, the conjugate binds to the hCG forming an antibody-antigen complex. This complex is captured by anti alpha hCG antibody on the test region to produces a visual pink color band when hCG concentration in specimen is equal to or greater than 25 mIU/ml. Regardless of the presence of hCG, as the mixture continues to move across the membrane to the control band region, the complex is captured by immobilized goat anti mouse antibodies to form a distinct pink colored control band. The presence of the control band indicated: 1) a normal flow is obtained, 2) antibody pre-coated on control line and colloidal gold conjugate are functional. 1 pc/individual pouch , 500pcs/ctn or customized
General Information One-Step Chlamydia Rapid Test (Swab/Urine) is detection of Chlamydia trachomatis in female cervical swab, male urethral swab and male urine specimens to aid in the diagnosis of Chlamydia infection. Detection limit:1*103IFU/ml Specimen: Swab/Urine Reading Time : 10min
General Information The Urinalysis Reagent Strips (Urine) are firm plastic strips onto which several separate reagent areas are affixed. The test is for the detection of one or more of the following analytes in urine: Ascorbic acid, Glucose, Bilirubin, Ketone (Acetoacetic acid), Specific Gravity, Blood, pH, Protein, Urobilinogen, Nitrite , Leukocytes and so on.
General Information Method: Double Antigens Sandwich Method Sensitivity : 99.5% Specificity : 98.8% Specimen : Serum / Plasma Reading Time : 5- 10 min
The Herpes Simplex Virus Rapid Test is a rapid qualitative lateral flow test designed for the quantitive detection of IgG antibodies to Herpes Simplex Virus (HSV) in human serum/plasma samples. HSV-1 is usually associated with infection in oropharyngeal area and eyes, while HSV-2 causes mostly genital and neonatal infections (5, 6), however, the tissue specificity is not absolute (7). HSV-2 can be isolated occasionally from the oropharynx and 5-10% of primary genital infections may be caused by HSV-1. Infants infected with HSV appear normal at birth, but almost invariably develop symptoms during the newborn period (5, 8, 9). Neonatal HSV infection may remain localized or become disseminated. Localized infection may involve one or a combination of sites. These are skin, eyes, mouth or the central nervous system. Disseminated infection is manifested by pneumonitis, hepatitis, disseminated intravascular coagulopathy and encephalitis. Of the infants with neonatal HSV, about one half of those surviving will develop severe neurological or ocular sequelae. A number of serological procedures have been developed to detect antibodies to HSV. These include complement fixation, indirect immunofluorescent antibody, plaque neutralization, and ELISA (6, 8, 10). Antibody of the IgG class is produced during the first 2-3 weeks of infection with HSV and exists only transiently in most patients. Serologic procedures, which measure the presence of IgG antibodies, help discriminate between primary and recurrent infections, since IgG antibodies is rarely found in recurrent infections. High affinity IgG antibodies to HSV, if present in a sample, may interfere with the detection of IgG specific antibody (9). High affinity IgG antibody may preferentially bind to HSV-1 antigen leading to false negative IgG results. Also, rheumatoid factor, if present, along with antigen specific IgG, may bind to IgG causing false positive IgG results. Both problems can be eliminated by deactivating IgG in the sample before testing for IgG.
Antibiotics Residue In Milk Rapid Test(Quinolone Rapid Test) INTENDED USE Quinolone Test is a competitive immunoassay for the semi-quantitative detection of the presence of Quinolone in milk. Cut-off: 50 ppb Assay Time: 10 �?? 15 min Sample: milk PRINCIPLE OF THE ASSAY Quinolone Test is based on competitive lateral flow immunochromatographic assay. The Quinolone conjugate in the test zone will capture the immuno-gold, when there is very little dissociative Quinolone in the sample. A visible red test band indicates a negative result when the control line shows that the card is valid. The test band will be not visible if Quinolone is present in concentration of 50 ppb and above which explains a positive result.
General Information One-Step Tetracycline Rapid Test is a competitive immunoassay for the semi-quantitative detection of the presence of Tetracycline residue in Milk,Honey,Tissue extract and Aquatic products. Detection limit: Milk 100 ppb ,Honey 20ppb , Tissue extract 100 ppb , Aquatic products 100ppb Specimen: Defatted milk, Honey, Tissue extract, Aquatic products Reading Time : 5-10min
General Information One-Step Beta-Lactam Rapid Test is a competitive immunoassay for the semi-quantitative detection of the presence of Beta-Lactam residue in milk. Specimen: Milk Reading Time : 5-10min
General Information One-Step Nitrofurans Rapid Test are competitive immunoassay for the semi-quantitative detection of the presence of AOZ,AMOZ, AHD, SEM residue in animal tissue. Detection limit:AOZ 1ppb , AMOZ 1ppb , AHD 1ppb , SEM 1ppb Specimen: Animal tissue Reading Time :10-15 min
One Step Troponin Test (Whole blood/Serum/Plasma FOR IN VITRO DIAGNOSTIC USE ONLY SPECIMEN COLLECTION 1. Testing should be performed immediately after the specimens have been collected. Do not leave the specimens at room temperature for prolonged periods. Specimens may be stored at 2-8C for up to 3 days. For long-term storage, specimens should be kept below -20C. 2. Bring specimens to room temperature prior to testing. Frozen specimens must be completely thawed and mixed well prior to testing. Specimens should not be frozen and thawed repeatedly. MATERIALS PROVIDED 1. Test cards individually foil pouched with a desiccant 2. Plastic dropper 3. Package insert MATERIALS REQUIRED BUT NOT PROVIDED 1. Timer/clock 2. Pipette 3. Controls ASSAY PROCEDURE 1. Read package insert carefully before testing. Allow the test devices, whole blood, serum or plasma to equilibrate to room temperature (15-30C) prior to testing. Do not open pouches until ready to perform the assay. 2. Remove the test device from the foil pouch and use it as soon as possible. 3. Place the test device on a clean and level surface. Hold the dropper provided vertically and transfer 3 drops of specimen (100�µl) to the specimen well (S) in the test device. 4. Wait for the red line(s) to appear. The result should be read between 10 to 15 minutes. INTERPRETATION OF RESULTS 1. Positive Two colored lines should be observed in the viewing window. The line in the test region (T) is the probe line; the line in the control region (C) is the control line, which is used to indicate proper performance of the device. The color intensity of the test line may be weaker or stronger than that of the control line. 2. Negative The control line appears in the test window, but the test line is not visible. 3. Invalid No line appears in the control region. Under no circumstances should a positive sample be identified until the control line forms in the viewing area. If the control line does not form, the test result is inconclusive and the assay should be repeated.
One Step Fecal Occult Blood (FOB) Rapid Test Cassette (Feces) Cat. No.: RH0301T INTENDED USE The One-Step Fecal Occult Blood (FOB) Diagnostic Kit is a qualitative detection of human occult blood in feces forself-testing. PRINCIPLE The One-Step Fecal Occult Blood (FOB) Diagnostic Kit is an immunochromatographic sandwich method, which employ two specific monoclonal antibodies to selectively identify hemoglobin in test samples. The result is very specific, and easier to interpret than those of guaiac-based test. The sensitivity is very high with the ability to detect 200ng/ml hemoglobin in feces. In addition, the accuracy of the test is not affected by interfering substances, and dietary restriction is not necessary. STORAGE The kits should be stored at temperature 4-30�°C, the sealed pouch for the duration of the shelf life (24 months). Do the test in 1 hour after open the pouch. WARNING AND PRECAUTIONS 1. For in vitro diagnostic use only. 2. Do not use kit beyond the expiration date. 3. Patient specimens may contain infectious agents and should be handled as though capable of transmitting disease. Wear disposable gloves throughout the specimen collection and assay procedures. 4. The test device should not be reused. REAGENTS AND MATERIALS PROVIDED 1. One pouched cassette with desiccant. 2. One operating Instruction MATERIALS REQUIRED BUT NOT PROVIDED 1. Clock or Timer SPECIMEN COLLECTION AND PREPARATION 1. Collect stool sample by using the sample collection device provided. 2. Unscrew the top of the sample collection device, take out the sample collection stick, and collect the sample by dipping the stick into 3 different places of the stool sample. 3. Put the sample collection stick back in the sample collection device and screw together tightly. 4. If the sample cannot be tested on the day of collection, store the stool sample at 4C. Bring the specimen to room temperature before testing. ASSAY PROCEDURE 1. Remove the test device from foil pouch by tearing along the notch. 2. Specimen collection. Please see also SAMPLE COLLECTION AND PREPARATION 3. Shake the sample collection device several times. 4. Holding the sample collection device upright, carefully unscrew the tip of collection device. 5. Squeeze 2-3 drops of the sample solution on the test sample pad. 6. Read the test results in 5 minutes. INTERPRETATION OF RESULTS Negative: Only one colored band appears on the control region (C). No colored band in the test region (T). Positive: In addition to the control band (C), a distinct colored band also appears in the test region (T). Invalid: If no bands appear, or a test band appears without a control band, the test should be repeated using a new test device.
INTENDED USE The Malaria Gold Rapid Test is a lateral flow chromatographic immunoassay for the simultaneous detection and differentiation of antibodies including IgG, IgM and IgA to Plasmodium falciparum (Pf) and vivax, ovale, and malariea (Pv.o.m) in whole blood. This device is intended to be used as a screening test and as an aid in the diagnosis of infection with Plasmodium. Any reactive specimen with the Malaria Gold Rapid Test must be confirmed with alternative testing method(s) and clinical findings. REAGENTS AND MATERIALS PROVIDED 1. Each kit contains 25 test devices, each sealed in a foil pouch with three items inside: a. One cassette device. b. One plastic dropper. c. One desiccant. 2. Sample diluent (1 vial, 5 ml) 3. One package insert (instruction for use). MATERIALS REQUIRED BUT NOT PROVIDED 1. Clock or Timer 2. Lancing device for whole blood test
INTENDED USE The Malaria Rapid Test is a lateral flow chromatographic immunoassay for the simultaneous detection and differentiation of Plasmodium falciparum (Pf) antigen and P. vivax, P. ovale, or P. Malariea antigen in whole blood. This device is intended to be used as a screening test and as an aid in the diagnosis of infection with Plasmodium. Any reactive specimen with the Malaria Rapid Test must be confirmed with alternative testing method(s) and clinical findings. SUMMARY AND EXPLANATION OF THE TEST Malaria is a mosquito-borne, hemolytic, febrile illness that infects over 200 million people and kills more than 1 million people per year. It is caused by four species of Plasmodium: P. falciparum, P. vivax, P.ovale, and P. malariae. These plasmodia all infect and destroy human erythrocytes, producing chills, fever, anemia, and splenomegaly. P. falciparum causes more sever disease than the other plasmodial species and accounts for most malaria deaths. P. falciparum and P. vivax are the most common pathogens, however, there is considerable geographic variation in species distribution1. Traditionally, malaria is diagnosed by the demonstration of the organisms on Giemsa stained smears of peripheral blood, and the different species of plasmodium are distinguished by their appearance in infected erythrocytes1. The technique is capable of accurate and reliable diagnosis, but only when performed by skilled microscopists using defined protocols2, which presents major obstacles for the remote and poor areas of the world. The Malaria Rapid Test is developed for solving these above obstacles. It detects the antibodies generated in serum or plasma in response to the infection of plasmodium. Utilizing the Pf. specific antigen (HRP-II) and pan-malaria antigen (aldolase), the test enables simultaneous detection and differentiation of the infection of P.falciparum and or P. vivax, ovale, and malariae3-5, by untrained or minimally skilled personnel, without laboratory equipment.
